Brief: Pharvaris Provides Clinical And Corporate Updates
Jan 9 (Reuters) - Pharvaris NV PHVS.O :
* PHARVARIS PROVIDES REGULATORY, CLINICAL, AND CORPORATE
UPDATES
* PHARVARIS NV - REMAINS DILIGENT IN ITS OPERATIONAL
MANAGEMENT
AND IS FOCUSING ON ITS EXISTING CLINICAL HAE PIPELINE TO EXTEND
RUNWAY INTO 4Q 2024
Source text for Eikon: ID:nGNX6JpZsn
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris NV
See all newsSwitzerland's Pharvaris Q1 loss per share narrows
Brief: Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox
U.S. STOCKS ON THE MOVE-Microsoft, Wyndham Hotels & Resorts, Daktronics
U.S. STOCKS ON THE MOVE-Wendy's, Bristol Myers Squibb, Macy's